Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2003
05/15/2003WO2003040103A1 β-SULFONE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003WO2002100836A3 Compounds, compositions and methods for modulating beta-amyloid production
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003US20030092912 Brain disorders, anticonvulsants, antidepressants, drug abruse
05/15/2003US20030092751 3-glyoxlylamideindoles for treating cancer
05/15/2003US20030092749 Kinase inhibitors; antiinflammatory agents; osteoporosis; anticancer agents
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092739 Pesticides
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092714 Heterocyclic inhibitors of ERK2 and uses thereof
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092694 Central nervous system disorders; side effect reduction
05/15/2003US20030092680 Novel pesticides
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092677 Glutamate receptor antagonists
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2465100A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors
05/14/2003EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309586A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
05/14/2003EP1309568A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309329A2 Therapeutic combination of a cetp inhibitor and atorvastatin
05/14/2003EP1278743A4 Novel anti-infectives
05/14/2003EP1140905B1 Heteroaromatic amides as inhibitor of factor xa
05/14/2003EP1109790B1 1, 2, 4-triazole-3-thione compounds
05/14/2003EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0934313B1 N-substituted azaheterocyclic compounds
05/14/2003EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562822 Heterocyle carboxamides as antiviral agents
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562792 Hygromycin derivatives
05/13/2003US6562759 Substituted phenyl uracils
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/13/2003CA2259655C 1,4-di-sustituted piperidines as muscarinic antagonists
05/13/2003CA2202992C Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037890A2 Piperidines
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037878A1 Substituted pyrimidines
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037346A1 6-phenyl-n-phenyl-(1,3,5) -triazine-2,4-diamine derivatives and related compounds with lysophphosphatidic acid acyltransferase beta (lpaat-beta) inhibitory activity for use in the treatment of cancer
05/08/2003WO2003037344A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037274A2 Pyrazole-amides and-sulfonamides
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030087952 17-Beta-hydroxysteroid dehydrogenase-II inhibitors
05/08/2003US20030087940 Substituted imidazoles and thiazoles
05/08/2003US20030087939 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/08/2003US20030087936 Treating enterovirus infection
05/08/2003US20030087931 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087925 Benzoamide piperidine containing compounds and related compounds
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087918 Substituted with purine or pyrimidine bases
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
05/08/2003US20030087882 Antiinflammatory agents
05/08/2003US20030087873 Treating a Flaviviridae, Orthomyxoviridae or Paramyxoviridae infection
1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 694